Fredun Pharmaceuticals Limited announced significant milestones in its business expansion and product development initiatives. Breakthrough Orders from SEA Countries: Fredun Pharmaceuticals has received large orders from Southeast Asian (SEA) countries, amounting to INR 280 million. These orders not only demonstrate the Company's growing presence in the international markets but also hold substantial potential to scale up over the years, signifying a promising avenue for future growth and market penetration.

Innovative Ventures in Veterinary Product Development: As part of its commitment to pioneering advancements in pet and veterinary care, Fredun Pharma has initiated the development of three new molecules. These ground-breaking formulations, the first of their kind in India, are poised to revolutionize the landscape of veterinary medicine, addressing critical needs and enhancing the well-being of companion animals. This strategic endeavour underscores the Company's dedication to innovation and meeting evolving market demands in the veterinary sector.

Advancements in Bone Graft Technology: Building on the success of its bone graft products, Fredun Pharma is proud to announce widespread acceptance by medical professionals. Encouraged by this positive response, the Company is expanding its focus on bone grafts for use in orthopaedic and veterinary applications. This strategic move reflects the Company's commitment to delivering high-quality healthcare solutions that positively impact patient outcomes and advance medical practices in both human and animal healthcare domains.